What's breaking now, across thousands of outlets.
Regenxbio said it no longer expects to file for FDA approval of its Hunter syndrome gene therapy in the near future after the program was slapped with its second clinical hold this year. The company ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
Salmonella is the group of bacteria behind one of the most common types of food poisoning in the UK, and while for most people it means a few unpleasant days at home, for others it can lead to serious…
(MedPage Today) -- A middle-aged man's persistent hiccups were a sign of a much more severe problem, clinicians wrote in a case report.
“He has tumors in his liver,” bandmate writes on GoFundMe. “Because of its location, doctors cannot safely operate to remove it at this time”
The restructuring comes after an unnamed "large pharmaceutical customer" terminated a contract with the company, Cellares CEO Fabian Gerlinghaus posted on LinkedIn.
If you're 70 or older, or 50 or older with underlying health conditions, and have tested positive for COVID, you might have been offered free or subsidized antivirals.
Nearly half of hospitalized COVID-19 patients had a dormant virus flare back to life, and one family of viruses found in the majority of people was tied to lasting symptoms from long COVID.
